S.L. 437.64 · Prohibition On The Use Of Certain (S.L. 437.64)
S.L. 437.64 Art. 6Exemptions from prohibitions.
(1) Saving the provisions in rules 4 and 5, the following shall be authorised:
(a) the administering to farm animals, for therapeutic purposes, of ßoestradiol 17, testosterone and progesterone and derivatives which readily yield the parent compound on hydrolysis after absorption at the site of application: Provided that, veterinary medicinal products used for therapeutic treatment must comply with the requirements for placing on the market laid down in European Union Directive 81/851/EEC and they must be administered only by a veterinarian, by injection or for the treatment of ovarian disfunction in the form of vaginal spirals, but not by implant, to farm animals which have been clearly identified. Treatment of [
identified animals must be registered by the veterinarian responsible. The latter must record at least the following details in a register, which may be the one provided for in European Union Directive 81/ 851/EEC:
(i) type of treatment;
(ii) the type of products authorised;
(iii) the date of treatment;
(iv) the identity of the animals treated: Provided also that the register must be made available to the Veterinary Services at its request;
(b) the administering for therapeutic purposes of authorised veterinary medicinal products containing:
(i) allyl trenbolone, administered orally, or betaagonists to equidae, provided they are used in accordance with the manufacturer’s instructions;
(ii) beta-agonists, in the form of an injection to induce tocolysis in cows when calving. Such substances must be administered by a veterinarian or, in the case of the veterinary medicinal products referred to in sub-paragraph (i), under his direct responsibility, treatment must be registered by the veterinarian responsible, who shall record at least the details referred to in paragraph (a). Farmers shall be prohibited from holding veterinary medicinal products containing beta-agonists which may be used for induction purposes in the treatment of tocolysis.
(2) Without prejudice to that mentioned in sub-rule (1), therapeutic treatment of production animals, including breeding animals at the end of their reproductive life, shall be prohibited.